Bausch Health Companies Inc. - 10 May 2022 Form 4 Insider Report for Bausch & Lomb Corp (BLCO)

Role: 10%+ Owner
Signature: /s/ Brianna Cetrulo, attorney-in-fact
Issuer symbol: BLCO
Transactions as of: 10 May 2022
Net transactions value: -$596,925,000
Form type: 4
Filing time: 12 May 2022, 16:18:04 UTC
Previous filing: 05 May 2022
Next filing: 02 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BLCO	Common Shares, No Par Value	Sale	$596,925,000	-35,000,000	-10%	$17.06	315,000,000	10 May 2022	See footnote	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reflects common shares, no par value ("Common Shares"), of Bausch + Lomb Corporation (the "Issuer") sold to the underwriters pursuant to an Underwriting Agreement, dated May 5, 2020, in connection with the initial public offering of the Issuer, which closed on May 10, 2022 (the "Offering"). The material terms of the Offering are described in the prospectus dated May 5, 2022, filed by the Issuer with the Securities and Exchange Commission on May 6, 2022.
F2	Reflects Common Shares owned directly and indirectly by the reporting person through a wholly-owned subsidiary of the reporting person.

Content

Reflects common shares, no par value ("Common Shares"), of Bausch + Lomb Corporation (the "Issuer") sold to the underwriters pursuant to an Underwriting Agreement, dated May 5, 2020, in connection with the initial public offering of the Issuer, which closed on May 10, 2022 (the "Offering"). The material terms of the Offering are described in the prospectus dated May 5, 2022, filed by the Issuer with the Securities and Exchange Commission on May 6, 2022.

Reflects Common Shares owned directly and indirectly by the reporting person through a wholly-owned subsidiary of the reporting person.